SCHEMBL1718992

SCHEMBL1718992

O=C(NCCN1CCOCC1)c1nn2c(C(F)(F)F)cc(-c3ccccc3)nc2c1Cl

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.69
MAPK1 P28482 1/20 0.64
ALDH1A1 P00352 6/20 0.56
GAA P10253 4/20 0.56
HPGD P15428 4/20 0.56
KDM4E B2RXH2 3/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
HTT P42858 1/20 0.56
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
MAPT P10636 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
CYP3A4 P08684 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
RXFP1 Q9HBX9 1/20 0.52
GLA P06280 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1718565 0.95 MAPK1 (0.69) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718370 0.93 USP2 (0.59) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718836 0.92 GAA (0.65) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1719737 0.88 GAA (0.61) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718369 0.83 RXFP1 (0.59) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718697 0.83 MAPK1 (0.69) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718567 0.82 KMT2A (0.65) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718280 0.82 MAPK1 (0.68) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL4197430 0.82 USP2 (1.00) USP2MAPK1ALDH1A1GAAHPGD
SCHEMBL1718805 0.82 ALDH1A1 (0.80) MAPK1ALDH1A1GAAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed